Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Here's How Much Twitter CEO Could Walk Away With If Elon Musk Shows Him The Door

Twitter Inc (NYSE: TWTR) CEO Parag Agrawal could stand to get a severance check worth over $40 million if he is terminated within 12 months of Tesla Inc (NASDAQ: TSLA) CEO Elon Musk takin

Twitter Workers In 'Dark' Will Get Opportunity To Get Answers From Elon Musk

Twitter Workers In 'Dark' Will Get Opportunity To Get Answers From Elon Musk

Twitter Inc (NYSE: TWTR) is in the "dark" over its future after it is all set to go private under Tesla Inc (NASDAQ: TSLA) CEO Elon Musk and employees at the company are slated to get an op

Fisker CEO Disappears From Twitter As Elon Musk Seals Takeover

Fisker CEO Disappears From Twitter As Elon Musk Seals Takeover

Fisker Inc (NYSE: FSR) CEO Henrik Fisker’s social media account disappeared from Twitter Inc (NYSE: TWTR) on Monday after Tesla Inc (NASDAQ:

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Why Nio, Other EV Peers Are Trading Higher In Hong Kong Today

Shares of Tesla Inc (NASDAQ: TSLA) rivals and U.S.-listed Chinese electric automakers Nio Inc (NYSE: NIO), Xpeng Inc (NYSE: XPEV<

'Everything In Its Right Place:' Jack Dorsey Reacts To Elon Musk's Twitter Takeover

Twitter Inc (NYSE: TWTR) founder Jack Dorsey tweeted a song by Radiohead titled “Everything In Its Right Place” after it was announced on the same day that Tesla Inc (NASDAQ: TSLA

Facebook Parent To Open Interactive Metaverse Store In California Amid Criticism Over Virtual Creator Tax

Meta Platforms Inc (NASDAQ: FB) will open a metaverse-themed interactive store in Burlingame, California.

No Knights Came To Twitter's Rescue As Musk Swooped Down, 'Soap Opera' Now Over, Says Analyst

Twitter Inc’s (NASDAQ: TWTR) board of directors had its back against the wall after Tesla Inc (NASDAQ: TSLA) CEO Elon Musk revealed he had secured funding to purchase the social media platform, said We

inkl

Read news from The Economist, FT, and more,
with one subscription

Twitter CEO Says No Job Cuts Planned Until Elon Musk's $44B Takeover Closes

Twitter CEO Says No Job Cuts Planned Until Elon Musk's $44B Takeover Closes

Twitter Inc (NYSE: TWTR) CEO Parag Agrawal told employees no layoffs were being planned until Tesla Inc (NASDAQ: TSLA) CEO&

$100 Invested In SVB Finl Gr 5 Years Ago Would Be Worth This Much

$100 Invested In SVB Finl Gr 5 Years Ago Would Be Worth This Much

SVB Finl Gr (NASDAQ:SIVB) has outperformed the market over the past 5 years by 12.82% on an annualized basis producing an average annual return of 25.3%. Currently, SVB Finl Gr has a market capitalization of $31.97 billion.

10 Financials Stocks Moving In Monday's After-Market Session

10 Financials Stocks Moving In Monday's After-Market Session

Gainers GWG Hldgs (NASDAQ:GWGH) stock moved upwards by 7.4% to $3.19 during Monday's after-market session. The company's market cap stands at $66.2 million.

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

Gainers Uxin (NASDAQ:UXIN) shares moved upwards by 6.2% to $0.85 during Monday's after-market session. The company's market cap stands at $337.7 million.

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session

12 Industrials Stocks Moving In Monday's After-Market Session

12 Industrials Stocks Moving In Monday's After-Market Session

Gainers American Rebel Holdings (NASDAQ:AREB) shares rose 5.3% to $1.2 during Monday's after-market session. The company's market cap stands at $5.6 million.

ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today

ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.97% at $4.97

Get all your
news in one place.

100's of premium titles.
One news app.

Twitter + Elon = Twitterverse Eruption: How The Social Media Platform's Denizens Reacted To Musk Buyout

It’s not surprising that #twittersold is the No. 1 trending topic on Twitter Inc (NYSE: TWTR) on the afternoon of April 25.

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach for a full day of networking and education.

Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach on April 19 for a full day of networking and education.

Protagonist Therapeutics Topline Data from Phase 2 IDEAL Study of PN-943 (450 mg BID) Miss Primary Endpoint

Protagonist Therapeutics (NASDAQ: PTGX) announced top-line results from the Phase 2 IDEAL clinical study evaluating PN-943 in patients with moderate-to-severe ulcerative colitis (UC).

Get all your
news in one place.

100's of premium titles.
One news app.

Cadence Design Systems Stock Gains On Q1 Earnings Beat, Solid FY22 Guidance

Cadence Design Systems Inc (NASDAQ:CDNS) reported first-quarter sales growth of 22.5% year-over-year to 901.77 million, beating the consensus of $857.32 million. Adjusted EPS improved to $1.17 from $0.83 in 1Q21, beating the consensus of $1.02. The operating income increased by 56.4% Y/Y to $318.93 million, and the margin expanded by 766 bps…

An Orange Ray Of Light For Truth Social? Trump Says 'No' To Twitter Return Despite Musk News

Former President Donald Trump, who was banned from Twitter Inc (NYSE: TWTR) in the wake of the Jan.

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ:WBA) and three other companies accused of fueling an opioid crisis in the city. San Francisco has alleged that Walgreens, Teva Pharmaceutical Industries Ltd (NYSE:TEVA), AbbVie Inc's (NYSE:ABBV) Allergan unit, and Teva-owned Anda Inc created a "public nuisance" by flooding the city with prescription opioids and failing…

Markets Pare Early Losses As Musk-Twitter Agree On Buyout Deal

U.S. indices pared early losses and closed higher Monday. Markets were trading lower to start the session as stocks continued to fall after the Fed last week indicated it may move more quickly on rate hikes to combat inflation. China’s COVID-19 outbreak has also added to global macro uncertainty.

First Busey Earnings Preview

First Busey (NASDAQ:BUSE) is set to give its latest quarterly earnings report on Tuesday, 2022-04-26. Here's what investors need to know before the announcement. Analysts estimate that First Busey will report an earnings per share (EPS) of $0.52.

What 9 Analyst Ratings Have To Say About SunPower

Over the past 3 months, 9 analysts have published their opinion on SunPower (NASDAQ:SPWR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

A Preview Of Goosehead Insurance's Earnings

Goosehead Insurance (NASDAQ:GSHD) is set to give its latest quarterly earnings report on Tuesday, 2022-04-26. Here's what investors need to know before the announcement. Analysts estimate that Goosehead Insurance will report an earnings per share (EPS) of $0.02.

1 … 649 650 651 652

People

186,169 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Ulcerative Colitis

Places

368,582 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play